Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: what is the evidence?
- PMID: 32562496
- DOI: 10.1111/dmcn.14606
Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: what is the evidence?
Comment on
-
Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial.Dev Med Child Neurol. 2020 Sep;62(9):1031-1039. doi: 10.1111/dmcn.14548. Epub 2020 Apr 27. Dev Med Child Neurol. 2020. PMID: 32342496 Clinical Trial.
References
-
- Nielsen S, Germanos R, Weier M, et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep 2018; 18: 8.
-
- Lattanzi S, Brigo F, Trinka E, et al. Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs 2018; 78: 1791-804.
-
- Fairhurst C, Kumar R, Checkett D, Taho B, Turner S. Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial. Dev Med Child Neurol 2020; 62: 1031-9.
-
- Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82: 1556-63.
-
- Nielsen S, Murnion B, Campbell G, Young H, Hall WD. Cannabinoids for the treatment of spasticity. Dev Med Child Neurol 2019; 61: 631-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical